Voice of America - July 24, 2007
Carole Gombakomba
Washington

A Zimbabwe HIV/AIDS activist said in testimony Tuesday on Capital Hill in Washington that she is disheartened to see continued high infection rates for women and girls.

Lucia Mbofana of Zimbabwe's Girl Child Network said Zimbabwe would make better progress towards reducing HIV infection rates if it were a focus country of the U.S. President's Emergency Plan for AIDS Relief, or PEPFAR, urging this change.

Though Zimbabwe is not a PEPFAR focus country, it does receive substantial aid for HIV/AIDS programs through USAID and various nongovernmental agencies.

Mbofana said poverty, poor education and cultural myths translate into higher levels of HIV infection through the sexual abuse of vulnerable young girls and women.

Mbofana told reporter Carole Gombakomba of VOA's Studio 7 for Zimbabwe that she hoped her appeal might increase Zimbabwe’s chances of becoming a PEPFAR focus country, especially as funding is proposed to double to US$30 billion over five years.

Congresswoman Betty McCollum, a Minnesota Democrat,joined global advocates in their call to put women and girls at the center of anti-AIDS efforts.

Rep. McCollum alluded to the recent statement by Dr. Anthony Fauci, a top advisor to President George Bush on HIV/AIDS, noting that for every person in the world being added to the ranks of those receiving antiretroviral therapy, six are becoming newly infected, and in Africa some 60% of those newly infected are women and girls.

070724
VA070720

Copyright © 2007 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .